Recent Regulatory Developments India’s biopharmaceutical industry stands at an inflection point where its scientific capabilities and production scale are increasingly recognized globa...
In recent years, India’s pharmaceutical landscape has witnessed a significant transformation. Beyond being the “pharmacy of the world” for affordable medicines, India is emerging as a preferred global...
Recent Investment and Ecosystem Highlights India’s biotech startup ecosystem is moving beyond early-stage experimentation into a phase of strategic innovation and scalable commercial ventur...
Key Highlights: Implications: CANTAB’s India entry taps the $1B+ digital diagnostics market (25% CAGR), challenging manual screening while accelerating early dementia detection amid ...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Key Highlights: Implications: Lantern’s Bengaluru expansion accelerates U.S. biotech offshoring of AI-drug discovery to India, intensifying talent competition with Dr. Reddy’s and Biocon w...
Relevant Industry Developments India’s biopharmaceutical sector is no longer defined solely by its global dominance in generics. Over the past decade, biologics and biosimilars have emerged as o...
